ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Eison TM , Ault BH , Jones DP , Chesney RW , Wyatt RJ , 2011. Post-streptococcal acute glomerulonephritis in children: Clinical features and pathogenesis. Pediatr Nephrol 26: 165–180.
-
2.
Worthing KA , Lacey JA , Price DJ , McIntyre L , Steer AC , Tong SYC , Davies MR , 2019. Systematic review of Group A Streptococcal emm types associated with acute post-streptococcal glomerulonephritis. Am J Trop Med Hyg 100: 1066–1070.
-
3.
Miller KM et al., 2022. Standardization of epidemiological surveillance of acute poststreptococcal glomerulonephritis. Open Forum Infect Dis 9: S57–S64.
-
4.
Satoskar AA , Parikh SV , Nadasdy T , 2020. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol 16: 32–50.
-
5.
Vogel AM , Lennon DR , van der Werf B , Diack M , Neutze JM , Horsfall M , Emery D , Wong W , 2018. Post-streptococcal glomerulonephritis: Some reduction in a disease of disparities. J Paediatr Child Health 55: 652–658.
-
6.
Wong W , Lennon DR , Crone S , Neutze JM , Reed PW , 2013. Prospective population-based study on the burden of disease from post-streptococcal glomerulonephritis of hospitalised children in New Zealand: Epidemiology, clinical features and complications. J Paediatr Child Health 49: 850–855.
-
7.
Trenholme A , Webb R , Lawrence S , Arrol S , Taylor S , Ameratunga S , Byrnes CA , 2021. COVID-19 and infant hospitalizations for seasonal respiratory virus infections, New Zealand, 2020. Emerg Infect Dis 27: 641–643.
-
8.
Baker MG et al., 2023. Continued mitigation needed to minimise the high health burden from COVID-19 in Aotearoa New Zealand. N Z Med J 136: 67–91.
-
9.
Chow EJ , Uyeki TM , Chu HY , 2023. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 21: 195–210.
-
10.
Hla TK , Cannon JW , Bowen AC , Wyber R , 2023. Getting to grips with invasive Group A streptococcal infection surveillance in Australia: Are we experiencing an epidemic? Med J Aust 219: 242–245.
-
11.
Statistics New Zealand , 2018. Statics NZ DataInfo+. Available at: https://datainfoplus.stats.govt.nz/. Accessed August 21, 2023.
-
12.
Te Whatu Ora Health NZ , 2023. Reducing Rheumatic Fever. Available at: https://www.tewhatuora.govt.nz/for-the-health-sector/health-sector-guidance/diseases-and-conditions/rheumatic-fever-guidance/reducing-rheumatic-fever/#first-episode-rheumatic-fever-hospitalisations-rate-per-100000-by-age-group-2022. Accessed August 17, 2023.
-
13.
Rodriguez-Iturbe B , 2021. Autoimmunity in acute poststreptococcal GN: A neglected aspect of the disease. J Am Soc Nephrol 32: 534–542.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1859 | 1859 | 168 |
| Full Text Views | 53 | 53 | 13 |
| PDF Downloads | 67 | 67 | 12 |
Reduction in Acute Post-Streptococcal Glomerulonephritis Incidence in Counties Manukau, New Zealand, after the COVID-19 Pandemic
Amanda Taylor
Amanda Taylor
Department of Paediatrics, The University of Auckland, Auckland, New Zealand;
Search for other papers by Amanda Taylor in
Current site
Google Scholar
PubMed
Search for other papers by Amanda Taylor in
Current site
Google Scholar
PubMed
Jocelyn Neutze
Jocelyn Neutze
Kidz First Children’s Hospital, Te Whatu Ora Counties Manukau, Auckland, New Zealand;
Search for other papers by Jocelyn Neutze in
Current site
Google Scholar
PubMed
Search for other papers by Jocelyn Neutze in
Current site
Google Scholar
PubMed
Nicole J. Moreland
Nicole J. Moreland
Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand;
Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland, New Zealand;
Search for other papers by Nicole J. Moreland in
Current site
Google Scholar
PubMed
Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Auckland, New Zealand;
Search for other papers by Nicole J. Moreland in
Current site
Google Scholar
PubMed
Rachel Webb
Rachel Webb
Department of Paediatrics, The University of Auckland, Auckland, New Zealand;
Kidz First Children’s Hospital, Te Whatu Ora Counties Manukau, Auckland, New Zealand;
Starship Children’s Health, Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand
Search for other papers by Rachel Webb in
Current site
Google Scholar
PubMed
Kidz First Children’s Hospital, Te Whatu Ora Counties Manukau, Auckland, New Zealand;
Starship Children’s Health, Te Whatu Ora Te Toka Tumai Auckland, Auckland, New Zealand
Search for other papers by Rachel Webb in
Current site
Google Scholar
PubMed
ABSTRACT.
The COVID-19 pandemic has altered the epidemiology of many common childhood infections, including Group A streptococcal (GAS) disease. Acute post-streptococcal glomerulonephritis (APSGN) is a nonsuppurative complication of GAS pharyngitis and pyoderma. It remains the most common cause of pediatric acute glomerulonephritis globally. In Counties Manukau, New Zealand, APSGN rates have previously been shown to be the highest in the country, with marked ethnic and socioeconomic disparities. We performed a retrospective review of children aged 0–14 years who were discharged from Kidz First Hospital, Counties Manukau, between 2015 and 2023 and met the Strep A Vaccine Global Consortium consensus definition of APSGN. We describe a marked, sustained reduction in APSGN hospitalizations, temporally associated with the COVID-19 pandemic. This ongoing reduction in APSGN incidence is notable in light of contrasting reports of increasing incidence of rheumatic fever in New Zealand and invasive GAS disease internationally.
Author Notes
Financial support: This work was supported by the
Authors’ addresses: Amanda Taylor, Department of Paediatrics, University of Auckland, Auckland, New Zealand, E-mail: amanda.taylor@auckland.ac.nz. Jocelyn Neutze and Rachel Webb, Kidz First Children’s Hospital, Te Whatu Ora Counties Manukau, Auckland, New Zealand, E-mails: jocelyn.neutze@middlemore.co.nz and rachel.webb@auckland.ac.nz. Nicole J. Moreland, Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, E-mail: n.moreland@auckland.ac.nz.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Eison TM , Ault BH , Jones DP , Chesney RW , Wyatt RJ , 2011. Post-streptococcal acute glomerulonephritis in children: Clinical features and pathogenesis. Pediatr Nephrol 26: 165–180.
-
2.
Worthing KA , Lacey JA , Price DJ , McIntyre L , Steer AC , Tong SYC , Davies MR , 2019. Systematic review of Group A Streptococcal emm types associated with acute post-streptococcal glomerulonephritis. Am J Trop Med Hyg 100: 1066–1070.
-
3.
Miller KM et al., 2022. Standardization of epidemiological surveillance of acute poststreptococcal glomerulonephritis. Open Forum Infect Dis 9: S57–S64.
-
4.
Satoskar AA , Parikh SV , Nadasdy T , 2020. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol 16: 32–50.
-
5.
Vogel AM , Lennon DR , van der Werf B , Diack M , Neutze JM , Horsfall M , Emery D , Wong W , 2018. Post-streptococcal glomerulonephritis: Some reduction in a disease of disparities. J Paediatr Child Health 55: 652–658.
-
6.
Wong W , Lennon DR , Crone S , Neutze JM , Reed PW , 2013. Prospective population-based study on the burden of disease from post-streptococcal glomerulonephritis of hospitalised children in New Zealand: Epidemiology, clinical features and complications. J Paediatr Child Health 49: 850–855.
-
7.
Trenholme A , Webb R , Lawrence S , Arrol S , Taylor S , Ameratunga S , Byrnes CA , 2021. COVID-19 and infant hospitalizations for seasonal respiratory virus infections, New Zealand, 2020. Emerg Infect Dis 27: 641–643.
-
8.
Baker MG et al., 2023. Continued mitigation needed to minimise the high health burden from COVID-19 in Aotearoa New Zealand. N Z Med J 136: 67–91.
-
9.
Chow EJ , Uyeki TM , Chu HY , 2023. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 21: 195–210.
-
10.
Hla TK , Cannon JW , Bowen AC , Wyber R , 2023. Getting to grips with invasive Group A streptococcal infection surveillance in Australia: Are we experiencing an epidemic? Med J Aust 219: 242–245.
-
11.
Statistics New Zealand , 2018. Statics NZ DataInfo+. Available at: https://datainfoplus.stats.govt.nz/. Accessed August 21, 2023.
-
12.
Te Whatu Ora Health NZ , 2023. Reducing Rheumatic Fever. Available at: https://www.tewhatuora.govt.nz/for-the-health-sector/health-sector-guidance/diseases-and-conditions/rheumatic-fever-guidance/reducing-rheumatic-fever/#first-episode-rheumatic-fever-hospitalisations-rate-per-100000-by-age-group-2022. Accessed August 17, 2023.
-
13.
Rodriguez-Iturbe B , 2021. Autoimmunity in acute poststreptococcal GN: A neglected aspect of the disease. J Am Soc Nephrol 32: 534–542.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1859 | 1859 | 168 |
| Full Text Views | 53 | 53 | 13 |
| PDF Downloads | 67 | 67 | 12 |